Trial Profile
Efficacy of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients With High Viral Load But Slight Aminotransferase Elevation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2022
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms TORCH-B
- 26 Jun 2022 Results assessing targeted long-read DNA Sequencing (DNA- Seq) to enable comprehensive analysis of the effect of TDF treatment on HBV integrations, presented at The International Liver Congress 2022.
- 26 Jun 2022 Results of a concurrent analysis assessing intrahepatic viral burden and liver immune microenvironment in chronic hepatitis B patients with minimally elevated serum alanine aminotransferase before and after treatment with tenofovir disoproxil fumarate presented at The International Liver Congress 2022
- 04 Jan 2022 Results published in the Gastroenterology